Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$31.56
At close: Jun 18, 4:00 PM EDT
$31.56
0.000.00%
Pre-Market: Jun 18, 4:00 PM EDT
Comments
Loading...
Option Care Health Analyst Ratings and Price Targets | NASDAQ:OPCH | Benzinga
Option Care Health Inc has a consensus price target of $35.44 based on the ratings of 8 analysts. The high is $41 issued by JP Morgan on March 6, 2025. The low is $27 issued by Goldman Sachs on November 5, 2024. The 3 most-recent analyst ratings were released by JMP Securities, Barrington Research, and UBS on June 18, 2025, April 30, 2025, and April 30, 2025, respectively. With an average price target of $38 between JMP Securities, Barrington Research, and UBS, there's an implied 20.41% upside for Option Care Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
Barrington Research
UBS
JP Morgan
Jefferies
1calculated from analyst ratings
Analyst Ratings for Option Care Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/18/2025 | Buy Now | 14.07% | JMP Securities | Constantine Davides41% | $36 → $36 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/30/2025 | Buy Now | 20.41% | Barrington Research | Michael Petusky49% | $38 → $38 | Maintains | Outperform | Get Alert |
| 04/30/2025 | Buy Now | 26.74% | UBS | A.J. Rice70% | $38 → $40 | Upgrade | Neutral → Buy | Get Alert |
| 04/22/2025 | Buy Now | 14.07% | JMP Securities | Constantine Davides41% | $36 → $36 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/21/2025 | Buy Now | 20.41% | Barrington Research | Michael Petusky49% | $38 → $38 | Maintains | Outperform | Get Alert |
| 03/06/2025 | Buy Now | 29.91% | JP Morgan | Lisa Gill56% | $40 → $41 | Maintains | Overweight | Get Alert |
| 02/27/2025 | Buy Now | 20.41% | Barrington Research | Michael Petusky49% | $33 → $38 | Maintains | Outperform | Get Alert |
| 01/24/2025 | Buy Now | 26.74% | JP Morgan | Lisa Gill56% | $38 → $40 | Maintains | Overweight | Get Alert |
| 01/23/2025 | Buy Now | 10.9% | Jefferies | Brian Tanquilut46% | $26 → $35 | Upgrade | Hold → Buy | Get Alert |
| 01/14/2025 | Buy Now | 4.56% | Barrington Research | Michael Petusky49% | $32 → $33 | Maintains | Outperform | Get Alert |
| 01/10/2025 | Buy Now | -4.94% | JMP Securities | Constantine Davides41% | $31 → $30 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/05/2024 | Buy Now | -17.62% | UBS | A.J. Rice70% | → $26 | Initiates | → Neutral | Get Alert |
| 11/05/2024 | Buy Now | -14.45% | Goldman Sachs | Jamie Perse63% | $38 → $27 | Downgrade | Buy → Neutral | Get Alert |
| 11/01/2024 | Buy Now | 7.73% | Truist Securities | David Macdonald65% | $41 → $34 | Maintains | Buy | Get Alert |
| 10/31/2024 | Buy Now | 1.39% | Barrington Research | Michael Petusky49% | $40 → $32 | Maintains | Outperform | Get Alert |
| 10/31/2024 | Buy Now | -17.62% | Jefferies | Brian Tanquilut46% | $38 → $26 | Downgrade | Buy → Hold | Get Alert |
| 10/23/2024 | Buy Now | 26.74% | Barrington Research | Michael Petusky49% | $40 → $40 | Maintains | Outperform | Get Alert |
| 09/30/2024 | Buy Now | 17.24% | JMP Securities | Constantine Davides41% | $36 → $37 | Maintains | Market Outperform | Get Alert |
| 08/01/2024 | Buy Now | 26.74% | Barrington Research | Michael Petusky49% | $38 → $40 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 20.41% | Barrington Research | Michael Petusky49% | $38 → $38 | Maintains | Outperform | Get Alert |
| 07/16/2024 | Buy Now | 14.07% | JMP Securities | Constantine Davides41% | → $36 | Initiates | → Market Outperform | Get Alert |
| 04/24/2024 | Buy Now | 20.41% | Barrington Research | Michael Petusky49% | → $38 | Maintains | Outperform | Get Alert |
| 03/04/2024 | Buy Now | 20.41% | Jefferies | Brian Tanquilut46% | $36 → $38 | Maintains | Buy | Get Alert |
| 02/23/2024 | Buy Now | 20.41% | Barrington Research | Michael Petusky49% | $35 → $38 | Maintains | Outperform | Get Alert |
| 10/26/2023 | Buy Now | 10.9% | Barrington Research | Michael Petusky49% | $41 → $35 | Maintains | Outperform | Get Alert |
| 10/18/2023 | Buy Now | 39.42% | JP Morgan | Lisa Gill56% | $46 → $44 | Maintains | Overweight | Get Alert |
| 07/28/2023 | Buy Now | 29.91% | Barrington Research | Michael Petusky49% | $34 → $41 | Maintains | Outperform | Get Alert |
| 06/27/2023 | Buy Now | 23.57% | Truist Securities | David Macdonald65% | → $39 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2023 | Buy Now | 7.73% | Barrington Research | Michael Petusky49% | $38 → $34 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 2.98% | Deutsche Bank | Pito Chickering68% | $39 → $32.5 | Maintains | Buy | Get Alert |
| 02/27/2023 | Buy Now | 20.41% | Jefferies | Brian Tanquilut46% | → $38 | Reinstates | → Buy | Get Alert |
| 10/28/2022 | Buy Now | 20.41% | Barrington Research | Michael Petusky49% | $37 → $38 | Maintains | Outperform | Get Alert |
| 08/22/2022 | Buy Now | 26.74% | Goldman Sachs | Jamie Perse63% | $31 → $40 | Maintains | Buy | Get Alert |
| 07/28/2022 | Buy Now | 17.24% | Barrington Research | Michael Petusky49% | $33 → $37 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Option Care Health (OPCH) stock?
The latest price target for Option Care Health (NASDAQ:OPCH) was reported by JMP Securities on June 18, 2025. The analyst firm set a price target for $36.00 expecting OPCH to rise to within 12 months (a possible 14.07% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Option Care Health (OPCH)?
The latest analyst rating for Option Care Health (NASDAQ:OPCH) was provided by JMP Securities, and Option Care Health reiterated their market outperform rating.
When was the last upgrade for Option Care Health (OPCH)?
The last upgrade for Option Care Health Inc happened on April 30, 2025 when UBS raised their price target to $40. UBS previously had a neutral for Option Care Health Inc.
When was the last downgrade for Option Care Health (OPCH)?
The last downgrade for Option Care Health Inc happened on November 5, 2024 when Goldman Sachs changed their price target from $38 to $27 for Option Care Health Inc.
When is the next analyst rating going to be posted or updated for Option Care Health (OPCH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Option Care Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Option Care Health was filed on June 18, 2025 so you should expect the next rating to be made available sometime around June 18, 2026.
Is the Analyst Rating Option Care Health (OPCH) correct?
While ratings are subjective and will change, the latest Option Care Health (OPCH) rating was a reiterated with a price target of $36.00 to $36.00. The current price Option Care Health (OPCH) is trading at is $31.56, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
